Analyst Consensus ?
ConsensusBuy61 ratings
Bullish3252.4%
Neutral2744.3%
Bearish23.3%
JPMorgan Chase & Co. · JPM · FY2024 Q4 · Calendar Q1 2025
JPMorgan: Strong quarter, but NII compression remains the key watchpoint
The supplied analysis supports a resilient franchise thesis: strong consumer, markets and wealth-management activity can offset near-term NII pressure, but credit costs, regulation and muted loan growth remain material tests.
Reported Before market openNYSEFinancial Services
$903.04B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $3.89
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $41.10B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+2.0%
Event window
SPY move
+1.8%
Same window
Abnormal move
+0.2%
Stock minus SPY
Volume
1.9×
Versus trailing sessions
Subsequent drift
+9.5%
Up to 20 sessions
JPMSPY benchmark
Ask FN2 about JPM FY2024 Q4
Transcript, numbers and history already loaded
What drove JPM's +2.0% move after FY2024 Q4 earnings?What changed in JPM's guidance and outlook in FY2024 Q4?Give me the bull and bear case for JPM after FY2024 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The latest analysis shifts the focus from broad franchise strength to the path of NII and capital deployment. Q4 performance was strong, but management expects rate normalization to compress NII before a recovery, while expenses increase modestly and loan growth stays cautious.
Guidance delta
Management maintained its outlook: NII may trough mid-year and resume growth in 2025, while expenses rise modestly for technology, auto leasing and branch expansion.
Key takeaways
- Management described record Q4 revenue and net income, with strength in consumer banking, markets and asset and wealth management.
- The central outlook issue is rate-driven NII compression, with a recovery expected after a mid-year trough.
- High excess capital points to continued share repurchases rather than a special dividend.
- Deposit balances have stabilized, while checking-account growth is improving.
- Loan growth remains a more cautious part of the outlook.
Management priorities
- Support card growth and revolving balances
- Expand asset and wealth management
- Invest in technology, auto leasing and branch expansion
- Use share repurchases to manage excess CET1
- Modernize technology platforms and develop products
Follow JPM with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$339.72Current
$120Low
$270.77Average
$425High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 18, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citigroup | Neutral | Neutral | Maintain | Oct 15, 2026 |
| Truist Securities | Hold | Hold | Maintain | Oct 14, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 14, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 14, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 14, 2026 |
| Baird | Neutral | Neutral | Maintain | Oct 14, 2026 |
| UBS | Buy | Buy | Maintain | Oct 5, 2026 |
| HSBC | Hold | Hold | Maintain | Sep 28, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 14, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 17, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 16, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Jul 15, 2026 |
| Jefferies | Hold | Hold | Maintain | Apr 15, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Apr 14, 2026 |
| Freedom Broker | Hold | Hold | Maintain | Jan 22, 2026 |
| TD Securities | Buy | Buy | Maintain | May 20, 2025 |
| Oppenheimer | Perform | Outperform | Downgrade | Nov 20, 2024 |
| Deutsche Bank | Hold | Buy | Downgrade | Sep 3, 2024 |
| BMO Capital | Market Perform | Market Perform | Maintain | Apr 15, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 1, 2024 |
| Daiwa Capital | Buy | Outperform | Maintain | Dec 18, 2023 |
| Atlantic Equities | Neutral | Neutral | Maintain | Aug 1, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 17, 2023 |
| Societe Generale | Hold | Buy | Downgrade | Jul 10, 2023 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jul 7, 2023 |
| Berenberg | Hold | Sell | Upgrade | Jul 18, 2022 |
| Seaport Global | Buy | Buy | Maintain | Jan 5, 2022 |
| DA Davidson | Buy | Buy | Maintain | Apr 15, 2021 |
| Independent Research | Hold | Buy | Downgrade | Dec 3, 2020 |
| DZ Bank | Buy | Hold | Upgrade | Mar 20, 2020 |
| Odeon Capital | Buy | Hold | Upgrade | Feb 3, 2020 |
| Buckingham Research | Neutral | Buy | Downgrade | Sep 16, 2019 |
| Buckingham | Neutral | Buy | Downgrade | Sep 16, 2019 |
| Bank of America | Buy | Buy | Maintain | Sep 17, 2018 |
| Argus | Buy | Buy | Maintain | May 5, 2018 |
| Nomura | Neutral | Neutral | Maintain | Feb 28, 2018 |
| Keefe Bruyette & Woods | Outperform | Market Perform | Upgrade | Feb 13, 2018 |
| Guggenheim | Buy | Neutral | Upgrade | Apr 25, 2017 |
| Sandler O'Neill | Hold | Buy | Downgrade | Oct 6, 2016 |
| CLSA | Buy | Buy | Maintain | Sep 23, 2016 |
| Macquarie | Neutral | Outperform | Downgrade | Sep 9, 2016 |
| Bernstein | Market Perform | Outperform | Downgrade | Aug 16, 2016 |
| Erste Group | Hold | Buy | Downgrade | Apr 25, 2016 |
| Portales Partners | Underperform | Sector Perform | Downgrade | Feb 22, 2016 |
| Argus Research | Buy | Buy | Maintain | Jan 15, 2016 |
| MKM Partners | Neutral | Buy | Downgrade | May 11, 2015 |
| Argus Capital | Buy | Hold | Upgrade | Oct 15, 2014 |
| FBR Capital | Outperform | Market Perform | Upgrade | Jul 21, 2014 |
| Rafferty Capital | Buy | Hold | Upgrade | Jul 15, 2014 |
| Rafferty | Buy | Hold | Upgrade | Jul 15, 2014 |
| Mediobanca Securities | Neutral | Outperform | Downgrade | Jan 28, 2014 |
| SunTrust Robinson Humphrey | Neutral | Buy | Downgrade | Dec 19, 2013 |
| Standpoint Research | Hold | Buy | Downgrade | Jul 24, 2013 |
| Raymond James | Strong Buy | Outperform | Upgrade | Jul 2, 2013 |
| ISI Group | Buy | Buy | Maintain | Feb 25, 2013 |
| Sterne Agee | Buy | Neutral | Upgrade | Jan 3, 2013 |
| Drexel Hamilton | Buy | Buy | Maintain | Oct 2, 2012 |
| JMP Securities | Underperform | Market Perform | Downgrade | May 21, 2012 |
| Stifel Nicolaus | Hold | Hold | Maintain | May 11, 2012 |
| Stifel | Hold | Buy | Downgrade | May 11, 2012 |
| Bank oferica | Buy | Buy | Maintain | Mar 27, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $339.72. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Analyst unavailable | $361 | $332.42 | +6.3% | Oct 14, 2026 |
| Robert W. Baird | David George | $312 | $331.43 | -8.2% | Oct 14, 2026 |
| Morgan Stanley | Manan Gosalia | $377 | $331.43 | +11.0% | Oct 14, 2026 |
| Barclays | Jason Goldberg | $425 | $331.43 | +25.1% | Oct 14, 2026 |
| Goldman Sachs | Analyst unavailable | $392 | $331.43 | +15.4% | Oct 13, 2026 |
| UBS | Analyst unavailable | $395 | $332.38 | +16.3% | Oct 5, 2026 |
| Wells Fargo | Analyst unavailable | $390 | $363.11 | +14.8% | Aug 14, 2026 |
| UBS | Erika Najarian | $400 | $355.27 | +17.7% | Aug 3, 2026 |
| Deutsche Bank | Analyst unavailable | $375 | $348.21 | +10.4% | Jul 22, 2026 |
| Truist Financial | John McDonald | $352 | $347.88 | +3.6% | Jul 15, 2026 |
| RBC Capital | Gerard Cassidy | $370 | $342.89 | +8.9% | Jul 15, 2026 |
| Robert W. Baird | David George | $305 | $342.89 | -10.2% | Jul 15, 2026 |
| Morgan Stanley | Analyst unavailable | $370 | $342.89 | +8.9% | Jul 15, 2026 |
| Barclays | Analyst unavailable | $420 | $342.89 | +23.6% | Jul 15, 2026 |
| Wells Fargo | Analyst unavailable | $375 | $342.89 | +10.4% | Jul 15, 2026 |
| Goldman Sachs | Analyst unavailable | $418 | $342.89 | +23.0% | Jul 14, 2026 |
| Jefferies | Analyst unavailable | $350 | $342.89 | +3.0% | Jul 14, 2026 |
| UBS | Erika Najarian | $384 | $340.79 | +13.0% | Jul 7, 2026 |
| Evercore ISI | Glenn Schorr | $360 | $336.13 | +6.0% | Jul 6, 2026 |
| Wells Fargo | Analyst unavailable | $360 | $334.47 | +6.0% | Jul 6, 2026 |
| Truist Financial | John McDonald | $344 | $331.96 | +1.3% | Jun 26, 2026 |
| Evercore ISI | Analyst unavailable | $340 | $312.25 | +0.1% | Apr 17, 2026 |
| Truist Financial | Analyst unavailable | $332 | $311.12 | -2.3% | Apr 15, 2026 |
| Robert W. Baird | Analyst unavailable | $295 | $311.12 | -13.2% | Apr 15, 2026 |
| Goldman Sachs | Analyst unavailable | $361 | $311.12 | +6.3% | Apr 14, 2026 |
| Truist Financial | Analyst unavailable | $323 | $291.66 | -4.9% | Mar 26, 2026 |
| Wells Fargo | Mike Mayo | $350 | $302.55 | +3.0% | Feb 17, 2026 |
| HSBC | Analyst unavailable | $319 | $310.16 | -6.1% | Feb 5, 2026 |
| Robert W. Baird | Analyst unavailable | $280 | $307.02 | -17.6% | Jan 14, 2026 |
| Truist Financial | Analyst unavailable | $334 | $307.8 | -1.7% | Jan 14, 2026 |
| RBC Capital | Gerard Cassidy | $330 | $307.87 | -2.9% | Jan 14, 2026 |
| HSBC | Saul Martinez | $245 | $327.21 | -27.9% | Jan 7, 2026 |
| Truist Financial | John McDonald | $331 | $334.04 | -2.6% | Jan 6, 2026 |
| Barclays | Analyst unavailable | $391 | $325.48 | +15.1% | Jan 5, 2026 |
| Truist Financial | John McDonald | $330 | $315.99 | -2.9% | Dec 18, 2025 |
| Morgan Stanley | Analyst unavailable | $331 | $300.47 | -2.6% | Dec 9, 2025 |
| Loop Capital Markets | Mikhail Paramonov | $310 | $294.84 | -8.7% | Oct 23, 2025 |
| Morgan Stanley | Analyst unavailable | $338 | $308.9 | -0.5% | Oct 15, 2025 |
| Barclays | Analyst unavailable | $342 | $302.08 | +0.7% | Oct 15, 2025 |
| Goldman Sachs | Analyst unavailable | $366 | $302.08 | +7.7% | Oct 14, 2025 |
| UBS | Analyst unavailable | $350 | $306.71 | +3.0% | Oct 7, 2025 |
| Goldman Sachs | Analyst unavailable | $330 | $315.69 | -2.9% | Sep 30, 2025 |
| Morgan Stanley | Betsy Graseck | $336 | $316.06 | -1.1% | Sep 29, 2025 |
| Citigroup | Keith Horowitz | $275 | $295.13 | -19.1% | Jul 7, 2025 |
| RBC Capital | Analyst unavailable | $305 | $289.91 | -10.2% | Jun 30, 2025 |
| Truist Financial | John McDonald | $270 | $260.71 | -20.5% | May 23, 2025 |
| Truist Financial | John McDonald | $261 | $234.72 | -23.2% | Apr 14, 2025 |
| Truist Financial | John McDonald | $264 | $210.28 | -22.3% | Apr 4, 2025 |
| Robert W. Baird | Analyst unavailable | $220 | $242.28 | -35.2% | Mar 7, 2025 |
| Evercore ISI | Glenn Schorr | $264 | $240 | -22.3% | Jan 2, 2025 |
| Oppenheimer | Chris Kotowski | $232 | $219.23 | -31.7% | Oct 14, 2024 |
| Robert W. Baird | David George | $200 | $222.29 | -41.1% | Oct 14, 2024 |
| Barclays | Jason Goldberg | $257 | $222.29 | -24.3% | Oct 14, 2024 |
| Evercore ISI | Glenn Schorr | $230 | $222.29 | -32.3% | Oct 14, 2024 |
| Citigroup | Keith Horowitz | $215 | $212.72 | -36.7% | Oct 10, 2024 |
| Barclays | Jason Goldberg | $217 | $204 | -36.1% | Sep 10, 2024 |
| KBW | David Konrad | $211 | $201.15 | -37.9% | Sep 10, 2024 |
| Deutsche Bank | Matt O'Connor | $235 | $224.8 | -30.8% | Sep 3, 2024 |
| Oppenheimer | Chris Kotowski | $221 | $210.2 | -34.9% | Jul 15, 2024 |
| Seaport Global | Analyst unavailable | $220 | $210.05 | -35.2% | Jul 15, 2024 |
| Piper Sandler | Scott Siefers | $230 | $204.94 | -32.3% | Jul 15, 2024 |
| New Street | David Konrad | $211 | $206.45 | -37.9% | Jul 10, 2024 |
| Jefferies | Ken Usdin | $239 | $208.83 | -29.6% | Jul 3, 2024 |
| Goldman Sachs | Richard Ramsden | $226 | $198.31 | -33.5% | May 23, 2024 |
| UBS | Erika Najarian | $224 | $195.58 | -34.1% | May 21, 2024 |
| Piper Sandler | Scott Siefers | $220 | $195.58 | -35.2% | May 21, 2024 |
| Robert W. Baird | David George | $185 | $195.58 | -45.5% | May 21, 2024 |
| RBC Capital | Gerard Cassidy | $211 | $195.58 | -37.9% | May 21, 2024 |
| UBS | Erika Najarian | $219 | $204.79 | -35.5% | May 20, 2024 |
| Jefferies | Ken Usdin | $227 | $198.77 | -33.2% | May 13, 2024 |
| Piper Sandler | Scott Siefers | $215 | $182.79 | -36.7% | Apr 15, 2024 |
| Oppenheimer | Chris Kotowski | $217 | $182.79 | -36.1% | Apr 15, 2024 |
| BMO Capital | James Fotheringham | $195 | $182.79 | -42.6% | Apr 15, 2024 |
| CFRA | Kenneth Leon | $215 | $183.81 | -36.7% | Apr 12, 2024 |
| Goldman Sachs | Richard Ramsden | $229 | $188 | -32.6% | Apr 12, 2024 |
| Morgan Stanley | Betsy Graseck | $221 | $188.31 | -34.9% | Apr 12, 2024 |
| Evercore ISI | Glenn Schorr | $210 | $195.43 | -38.2% | Apr 12, 2024 |
| J.P. Morgan | David Konrad | $195 | $194.58 | -42.6% | Apr 10, 2024 |
| Wells Fargo | Mike Mayo | $220 | $196.33 | -35.2% | Mar 20, 2024 |
| Wells Fargo | Matt O'Connor | $190 | $170.66 | -44.1% | Jan 9, 2024 |
| Deutsche Bank | Matt O'Connor | $190 | $170.66 | -44.1% | Jan 9, 2024 |
| Oppenheimer | Chris Kotowski | $215 | $145.81 | -36.7% | Oct 13, 2023 |
| Raymond James | James Fotheringham | $170 | $152.61 | -50.0% | Jul 17, 2023 |
| Citigroup | Keith Horowitz | $160 | $148.15 | -52.9% | Jul 13, 2023 |
| RBC Capital | Gerard Cassidy | $140 | $138.16 | -58.8% | Apr 17, 2023 |
| Wells Fargo | Mike Mayo | $158 | $138.73 | -53.5% | Apr 17, 2023 |
| Oppenheimer | Analyst unavailable | $186 | $139.59 | -45.2% | Feb 2, 2023 |
| Deutsche Bank | Analyst unavailable | $145 | $135.35 | -57.3% | Jan 6, 2023 |
| Barclays | Analyst unavailable | $189 | $134.1 | -44.4% | Jan 3, 2023 |
| Oppenheimer | Analyst unavailable | $169 | $132.46 | -50.3% | Dec 28, 2022 |
| Citigroup | Analyst unavailable | $150 | $133.33 | -55.8% | Dec 12, 2022 |
| Piper Sandler | Analyst unavailable | $150 | $131.5 | -55.8% | Dec 8, 2022 |
| Deutsche Bank | Analyst unavailable | $155 | $120.98 | -54.4% | Sep 12, 2022 |
| UBS | Erika Najarian | $126 | $114 | -62.9% | Jul 27, 2022 |
| Oppenheimer | Chris Kotowski | $153 | $113.18 | -55.0% | Jul 26, 2022 |
| Berenberg Bank | Peter Richardson | $120 | $112.95 | -64.7% | Jul 18, 2022 |
| Piper Sandler | Jeffery Harte | $158 | $113.14 | -53.5% | Jul 11, 2022 |
| Morgan Stanley | Betsy Graseck | $149 | $118.78 | -56.1% | Jun 28, 2022 |
| BMO Capital | Analyst unavailable | $156 | $123.6 | -54.1% | May 24, 2022 |
| Morgan Stanley | Analyst unavailable | $152 | $118.43 | -55.3% | May 19, 2022 |
| Jefferies | Ken Usdin | $125 | $119.09 | -63.2% | May 16, 2022 |
| Oppenheimer | Chris Kotowski | $167 | $123.03 | -50.8% | May 4, 2022 |
| Piper Sandler | Jeffery Harte | $170 | $128.46 | -50.0% | Apr 18, 2022 |
| Evercore ISI | Glenn Schorr | $150 | $126.12 | -55.8% | Apr 14, 2022 |
| Jefferies | Ken Usdin | $141 | $133 | -58.5% | Apr 11, 2022 |
| Barclays | Jason Goldberg | $200 | $133.34 | -41.1% | Apr 5, 2022 |
| Wells Fargo | Mike Mayo | $150 | $134.91 | -55.8% | Apr 4, 2022 |
| Jefferies | Ken Usdin | $155 | $152.14 | -54.4% | Feb 20, 2022 |
| UBS | Erika Najarian | $197 | $145.08 | -42.0% | Jan 23, 2022 |
| Citigroup | Keith Horowitz | $175 | $150.16 | -48.5% | Jan 18, 2022 |
| Credit Suisse | Susan Roth Katzke | $184 | $156.73 | -45.8% | Jan 17, 2022 |
| KBW | David Konrad | $157 | $156.73 | -53.8% | Jan 17, 2022 |
| BMO Capital | James Fotheringham | $141 | $156.73 | -58.5% | Jan 17, 2022 |
| Goldman Sachs | Richard Ramsden | $194 | $156.73 | -42.9% | Jan 14, 2022 |
| Deutsche Bank | Matt O'Connor | $185 | $156.73 | -45.5% | Jan 14, 2022 |
| Societe Generale | Andrew T Lim | $175 | $162.57 | -48.5% | Jan 5, 2022 |
| Wolfe Research | Steven Chubak | $185 | $165.6 | -45.5% | Jan 4, 2022 |
| Berenberg Bank | Peter Richardson | $125 | $164.4 | -63.2% | Oct 15, 2021 |
| Bank of America Securities | Ebrahim Poonawala | $190 | $167.96 | -44.1% | Oct 8, 2021 |
| Atlantic Equities | John Heagerty | $150 | $147.5 | -55.8% | Apr 27, 2021 |
Track every rating change on JPM the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationJPMorgan Chase & Co. operates as a bank and financial holding company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia Pacific, Latin America, and the Caribbean. It operates in three segments: Consumer & Community Banking, Commercial & Investment Bank, and Asset & Wealth Management. The company offers deposit, investment and lending products, and cash management; mortgage origination and servicing activities; residential mortgages and home equity loans; and credit cards, payment solutions, travel services, merchant offers, lifestyle benefits, auto loans, and leases to consumers and small businesses through bank branches, ATMs, and digital and telephone banking.…
Historical context
All JPM earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| MTB-PH M&T Bank Corporation | FY2026 Q3 · Calendar Q4 2026 | +2.2% | — | M&T Bank: Loan Growth Holds Up as Rates Pressure Margins |
| MTB-PJ M&T Bank Corporation | FY2026 Q3 · Calendar Q4 2026 | +2.2% | — | M&T: Deposit growth supports margins as AI use expands |
| RF-PE Regions Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | +10.3% | — | Regions Financial: Fee Growth and Credit Quality Support Q3 |
| RF-PC Regions Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | +10.3% | — | Regions Financial: Fee growth supports a steady Q3 outlook |
| TFC-PI Truist Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | -50.9% | — | Truist sharpens focus as Q3 EPS rises 12% |
| TRV The Travelers Companies, Inc. | FY2026 Q3 · Calendar Q4 2026 | +24.2% | +1.5% | Travelers posts strong Q3, with investment income above $900 million |
Latest beats and misses
Who reports nextBeat on EPS
Get the JPM recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-01-01T00:00:06.762947+00:00
- Polygon adjusted daily market bars · 2026-10-18T11:00:42.221091+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-18T11:00:42.218294+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-18. For educational purposes only; not investment advice.